Have a personal or library account? Click to login

Occult hepatitis B virus infection in people with haemophilia in South Africa

Open Access
|Jun 2025

References

  1. World Health Organization. Global hepatitis report 2024: Action for access in low-and middle-income countries. April 2024. Available from https://www.who.int/publications/i/item/9789240091672 (accessed May 2025).
  2. World Health Organization. Hepatitis B. Available from https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b (accessed May 2025).
  3. Zampino R, Boemio A, Sagnelli C, et al. 2015. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42):11941. doi: 10.3748/wjg.v21.i42.11941.
  4. Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet 2015; 386(10003):1546–55. doi: 10.1016/S0140-6736(15)61412-X.
  5. Kiire C. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa. Gut 1996; 38(Suppl 2): S5–12. doi: 10.1136/gut.38.suppl_2.s5.
  6. Kew MC. Hepatitis B virus infection: The burden of disease in South Africa. Southern African Journal of Epidemiology and Infection 2008; 23(1): 4–8. doi: 10.1080/10158782.2008.11441293.
  7. Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ 2020; 370: m2200. doi: https://doi.org/10.1136/bmj.m2200
  8. Yip TCF, Wong GLH. Current knowledge of occult hepatitis B infection and clinical implications. Semin Liver Dis 2019; 39(2): 249–60. doi: 10.1055/s-0039-1678728.
  9. Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 2019; 71(2):397–408. doi: 10.1016/j.jhep.2019.03.034
  10. Ocana S, Casas ML, Buhigas I, Lledo JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011; 17(12):1553. doi: 10.3748/wjg.v17.i12.1553.
  11. Kramvis A. Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus. S Afr Med J 2018; 108(8):17–21. doi: 10.7196/samj.2018.v108i8.13495.
  12. Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North American Journal of Medicine and Science 2011; 4(1):7–13. Available from https://najms.com/index.php/najms/article/view/499 (accessed May 2025).
  13. Im YR, Jagdish R, Leith D, et al. Prevalence of occult hepatitis B virus infection in adults: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022; 7(10): 932–42. doi: 10.1016/S2468-1253(22)00201-1.
  14. Weusten J, Van Drimmelen H, Vermeulen M, Lelie N. A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios. Transfusion 2017; 57(3pt2): 841–9. doi: 10.1111/trf.14050.
  15. Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol 2017; 24(3): 189–95. doi: 10.1016/j.tracli.2017.06.014.
  16. Makris M, Preston F, Triger D, et al. Hepatitis c antibody and chronic liver disease in haemophilia. Lancet 1990; 335(8698): 1117–9. doi: 10.1016/0140-6736(90)91124-S.
  17. Merritt EC. Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes. [cited 2024; 2024/08/05]. Available from: https://lordslibrary.parliament.uk/infected-blood-scandal-background-impacts-interim-compensation-and-inquiry-outcomes.
  18. Teitel JM. Viral safety of haemophilia treatment products. Ann Med 2000; 32(7):485–92. doi: 10.3109/07853890009002024.
  19. Allain JO, Belkhiri D, Vermeulen M, et al. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009; 49(6): 1868–76. doi: 10.1002/hep.22879.
  20. Bell TG, Makondo E, Martinson NA, Kramvis A. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: Occult or overt–that is the question. PLoS One 2012; 7(10): e45750. doi: 10.1371/journal.pone.0045750.
  21. Msomi N|, Ndlovu K, Gianhari J, et al. High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal, South Africa. J Med Virol 2019; 91(10): 1797–803. doi: 10.1002/jmv.25510.
  22. Javanmard D, Namaei MH, Farahmand M, et al. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. J Med Virol 2019; 91(8): 1519–27. doi: 10.1002/jmv.25470.
  23. Toyoda H, Hayashi K, Murakami Y, et al. Prevalence and clinical implications of occult hepatitis b viral infection in hemophilia patients in Japan. J Med Virol 2004; 73(2): 195–9. doi: 10.1002/jmv.20075.
  24. Varaklioti A, Kouramba A, Ioannidou P, Katsarou O. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders. Infect Genet Evol 2017; 54: 397–401. doi: 10.1016/j.meegid.2017.07.012.
  25. Windyga J, Brojer E, Gronowska A, et al. Preliminary results of HBV DNA testing of Polish haemophilia patients–lack of occult HBV infection. Haemophilia 2006; 12(4): 380–3. doi: 10.1111/j.1365-2516.2006.01293.x.
  26. Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub-Saharan Africa: Strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol 2017; 2(12): 900–9. doi: 10.1016/S2468-1253(17)30295-9.
  27. Vermeulen M, Swanevelder R, Van Zyl G, Lelie N, Murphy EL. An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safety. Transfusion 2021; 61(9): 2688–700. doi: 10.1111/trf.16559.
  28. European Medicines Agency. Guideline on plasma-derived medicinal products. 21 July 2011. EMA/CHMP/BWP/706271/2010. Available from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-plasma-derived-medicinal-products_en.pdf (accessed June 2025).
  29. Samal J, Kandpal M. Vivekandandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 2012; 25(1): 142–63. doi: 10.1128/CMR.00018-11.
Language: English
Page range: 65 - 70
Published on: Jun 10, 2025
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2025 O Kgotleng, N Msomi, LD Mthethwa, J Potgieter, JN Mahlangu, M Karodia, NL Ntabeni, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.